Intelligence Feed event · Capital · 2026-10-19

    Bavarian Nordic advances DKK 250M buyback, reaching 5.53% of capital

    Question

    Bavarian Nordic advances DKK 250M buyback, reaching 5.53% of capital

    Direct answer

    Bavarian Nordic announced the latest transaction figures under its DKK 250 million share repurchase program launched on September 1, 2026. During the week of October 12-16, the vaccine manufacturer repurchased 167,886 shares at an average price of DKK 237.92. Total accumulated repurchases have now reached 824,213 shares, accounting for 5.53% of the company's registered share capital. The execution demonstrates steady balance sheet capital return amidst ongoing European commercial vaccine distribution.

    Original publisher
    Market Ontology
    Evidence through
    2026-10-19
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Bavarian Nordic advances DKK 250M buyback, reaching 5.53% of capital”, revision 1, evidence through 2026-10-19. https://marketontology.com/market-events/2026-10-19/bavarian-nordic-advances-dkk-250m-buyback-reaching-5-53-of-capital-c07353

    CAPITAL
    Bavarian Nordic advances DKK 250M buyback, reaching 5.53% of capital
    Bavarian Nordic announced the latest transaction figures under its DKK 250 million share repurchase program launched on September 1, 2026. During the week of October 12-16, the vaccine manufacturer repurchased 167,886 shares at an average price of DKK 237.92. Total accumulated repurchases have now reached 824,213 shares, accounting for 5.53% of the company's registered share capital. The execution demonstrates steady balance sheet capital return amidst ongoing European commercial vaccine distribution.
    BVNRY
    Impact
    57
    OCT 19
    SIG
    88%
    BVNRY
    Bavarian Nordic advances DKK 250M buyback, reaching 5.53% of capital
    Bavarian Nordic announced the latest transaction figures under its DKK 250 million share repurchase program launched on September 1, 2026. During the week of October 12-16, the vaccine manufacturer repurchased 167,886 shares at an average price of DKK 237.92. Total accumulated repurchases have now reached 824,213 shares, accounting for 5.53% of the company's registered share capital. The execution demonstrates steady balance sheet capital return amidst ongoing European commercial vaccine distribution.
    → Targeted corporate repurchases absorbing 5.53% of Bavarian Nordic shares reduce tradable free float, providing downside price support on the Copenhagen exchange.
    Impact
    Bavarian Nordic announced the latest transaction figures under its DKK 250 million share repurchase program launched on September 1, 2026. During the week of October 12-16, the vaccine manufacturer repurchased 167,886 shares at an average price of DKK 237.92. Total accumulated repurchases have now reached 824,213 shares, accounting for 5.53% of the company's registered share capital. The execution demonstrates steady balance sheet capital return amidst ongoing European commercial vaccine distribution.
    Affected
    BVNRY
    Transmission
    Targeted corporate repurchases absorbing 5.53% of Bavarian Nordic shares reduce tradable free float, providing downside price support on the Copenhagen exchange.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    BVNRYopen-market buyback reducing free float sharesUp1-5dRepurchases total 5.53% of share capital under active DKK 250M program.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    AssetCallBase close+1 day+5 days+20 days
    BVNRYUp11.63 2026-10-14PendingPendingPending

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month